Fundraising FoxBioverge
also invests · investor profileSan Francisco, US · Delaware corporation · 1 known investors
Find your way into Bioverge
Sign up to see every warm intro you have to Bioverge
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bioverge team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
NL
Neil LittmanFounder
RG
Richard GibbNamed on SEC filing
Investors · 1
Flucas Ventureslisted by Flucas VenturesJupiter · $100K – $5Mvia Ashley Flucas · inferred
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 3 rounds · 2018–2022
▶$148.5KraisedMay 2023 · 4 investors · Other TechnologyRule 506(b)
▶$148.5KraisedMay 2023 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Neil LittmanExecutive Officer, Director
- Richard GibbExecutive Officer
- Offering amount
- $148.5K
- Amount sold
- $148.5K
- Minimum investment
- $5K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$775KraisedMay 2023 · 21 investors · Other TechnologyRule 506(b)
▶$775KraisedMay 2023 · 21 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Neil LittmanExecutive Officer, Director
- Richard GibbExecutive Officer
- Offering amount
- $775K
- Amount sold
- $775K
- Minimum investment
- $5K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$588.5KraisedMay 2023 · 23 investors · Other TechnologyRule 506(b)
▶$588.5KraisedMay 2023 · 23 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Richard GibbExecutive Officer
- Neil LittmanExecutive Officer, Director
- Offering amount
- $600K
- Amount sold
- $588.5K
- Minimum investment
- $5K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Time BioVenturesTime BioVentures is a venture capital firm that invests in life sciences and healthcare startups developing new medical and biotech technologies. It is based in Southern California.
SuperscoutSuperscout operates a network platform connecting investors with pre-screened early-stage startups through a distributed scout network, offering access to deal-flow across diverse geographies and demographics without upfront fees. The service uses a carry-share compensation model aligned with investor returns.
Companies working in the same space as Bioverge.
Legal entities · 1
corporate structureBiovergeDelaware
In the news
Frequently asked questions
- Who founded Bioverge?
- Bioverge was founded by Neil Littman.
- Who are Bioverge's investors?
- Bioverge's investors include Flucas Ventures.
- How much funding has Bioverge raised?
- Bioverge has disclosed $1.5M raised across 3 rounds.
- Where is Bioverge headquartered?
- Bioverge is headquartered in San Francisco, US.